290 related articles for article (PubMed ID: 32062294)
1. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
2. Sound preconditioning therapy inhibits ototoxic hearing loss in mice.
Roy S; Ryals MM; Van den Bruele AB; Fitzgerald TS; Cunningham LL
J Clin Invest; 2013 Nov; 123(11):4945-9. PubMed ID: 24216513
[TBL] [Abstract][Full Text] [Related]
3. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
4. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
Bielefeld EC
Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
[TBL] [Abstract][Full Text] [Related]
5. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
6. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
[TBL] [Abstract][Full Text] [Related]
7. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
8. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
9. Assessment of thermal treatment via irrigation of external ear to reduce cisplatin-induced hearing loss.
Spankovich C; Lobarinas E; Ding D; Salvi R; Le Prell CG
Hear Res; 2016 Feb; 332():55-60. PubMed ID: 26639015
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
[TBL] [Abstract][Full Text] [Related]
11. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Kim HJ; Pandit A; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473
[TBL] [Abstract][Full Text] [Related]
12. Korean red ginseng ameliorates acute 3-nitropropionic acid-induced cochlear damage in mice.
Tian C; Kim YH; Kim YC; Park KT; Kim SW; Kim YJ; Lim HJ; Choung YH
Neurotoxicology; 2013 Jan; 34():42-50. PubMed ID: 23164932
[TBL] [Abstract][Full Text] [Related]
13. Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?
Saliba I; El Fata F
Neurotox Res; 2012 Apr; 21(3):302-8. PubMed ID: 21989624
[TBL] [Abstract][Full Text] [Related]
14. Ototoxicity of 12 mg/kg cisplatin in the Fischer 344/NHsd rat using multiple dosing strategies.
Harrison RT; Seiler BM; Bielefeld EC
Anticancer Drugs; 2016 Sep; 27(8):780-6. PubMed ID: 27467178
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cochlear toxicity in response to chronic 3,3'-iminodipropionitrile in mice reveals early and reversible functional loss that precedes overt histopathology.
Greguske EA; Llorens J; Pyott SJ
Arch Toxicol; 2021 Mar; 95(3):1003-1021. PubMed ID: 33495873
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
[TBL] [Abstract][Full Text] [Related]
19. FGF22 protects hearing function from gentamycin ototoxicity by maintaining ribbon synapse number.
Li S; Hang L; Ma Y
Hear Res; 2016 Feb; 332():39-45. PubMed ID: 26639016
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo.
Wang AM; Sha SH; Lesniak W; Schacht J
Antimicrob Agents Chemother; 2003 Jun; 47(6):1836-41. PubMed ID: 12760856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
